Reading this on a mobile device? Try our optimized mobile version here:

February 25, 2013
Sign upForwardArchive
News for the PBM Industry

  Featured Story 
  • Health care would see sweeping changes under sequestration
    Spending cuts mandated under sequestration, looking increasingly likely, will touch nearly all aspects of health care, including potentially forcing layoffs or furloughs at the FDA. "The FDA is having enough trouble retaining their good people," said Dan Mendelson of Avalere Health. "I would expect approval times to suffer as a result." Delaying Affordable Care Act provisions such as exchanges could help prevent the cuts, according to Republican Gov. Bobby Jindal of Louisiana. The Hill/Healthwatch blog (2/24), The Washington Post/Post Politics blog (2/24) LinkedInFacebookTwitterEmail this Story
 Registration is now open for PCMA's Specialty Pharmacy Business Forum!
The SPBF provides individuals and companies in the specialty pharmacy chain of commerce with exceptional educational and business networking opportunities. A unique aspect of the conference is "PCMA-Connect," an online networking community that will give attendees the opportunity to search for, connect, and coordinate meetings with existing and potential business customers and partners.

  Legislative & Regulatory News 
  Drug Industry Spotlight 
  • Drugmakers ask court to reconsider generic-drugs decision
    Drugmakers, the U.S. Chamber of Commerce and other organizations are asking the Alabama Supreme Court to reconsider a ruling that makes brand-name drugmakers liable for injuries caused by generic versions of treatments. A 2011 U.S. Supreme Court decision that protected makers of generics left the Alabama court with few options, said John Fuson, a former FDA associate chief counsel. The Wall Street Journal (2/24) LinkedInFacebookTwitterEmail this Story
  • Study: Many veterans with heartburn may stay on PPIs for too long
    Researchers looked at the records of 1,600 veterans with chronic heartburn who were prescribed proton pump inhibitors and found that a majority were given more than a three-month supply of these drugs and almost 25% were prescribed high doses. Data also showed that a majority of the veterans on high doses were still taking the drug two years after the first prescription without any reduction in dose. The study appeared in the Journal of General Internal Medicine. HealthDay News (2/22) LinkedInFacebookTwitterEmail this Story
  • Other News
It is wonderful how much news there is when people write every other day; if they wait for a month, there is nothing that seems worth telling."
--Anna Masterton Buchan,
Scottish writer


Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Contact PCMA
Charles Cote
Vice President, Strategic Communications
(202) 207-3610

Twitter  Follow PCMA on Twitter
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

 Recent PCMA SmartBrief Issues:   Lead Editor:  Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information